Omeros Corp

Pharmaceutical company · Seattle, Washington, United States · Nasdaq: OMER

Omeros Corp is a pharmaceutical company headquartered in Seattle, Washington, United States. Its shares trade on Nasdaq under the ticker OMER. It has received 15 US government small-business research awards (SBIR/STTR) from health agencies, $5.4 million in total, most recently in 2012.

Profile compiled from public records. Is this your company? Request a correction or update

Omeros at a glance

Typepharmaceutical company

HeadquartersSeattle, Washington, United States

Stock listingNasdaq: OMER

SEC industryPharmaceutical Preparations

SEC CIK1285819

What does Omeros do?

US government research funding

15 SBIR/STTR small-business research awards from US health agencies, $5.4 million in total (1999 to 2012).

Frequently asked questions about Omeros

Where is Omeros headquartered?

Omeros Corp is headquartered in Seattle, Washington, United States.

What does Omeros do?

Omeros Corp is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Omeros a public company?

Yes. Omeros Corp trades on Nasdaq under the ticker OMER.

Similar companies

Chinook Therapeutics, Inc.Seattle, Washington, United States
Cti Biopharma CorpSeattle, Washington, United States
Perspective Therapeutics, Inc.Seattle, Washington, United States
Aptevo Therapeutics Inc.Seattle, Washington, United States
IPI Legacy Liquidation CoSeattle, Washington, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.